Bonomarlot
Bonomarlot is a complex peptide bioregulator preparation derived from bone marrow tissue, developed at the St. Petersburg Institute of Bioregulation and Gerontology. Research focuses on its effects on hematopoiesis, immune reconstitution through bone marrow stimulation, and recovery from myelosuppressive conditions.
Bonomarlot is a complex peptide preparation obtained from bone marrow tissue, belonging to the Cytomed class of bioregulators developed under the direction of Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology.
Overview
Bonomarlot belongs to the class of complex peptide bioregulators known as cytomedines — preparations obtained by acid extraction of tissue-specific peptides from animal organs. The cytomedine concept, developed by Khavinson and colleagues beginning in the 1970s, holds that each tissue produces a characteristic set of short regulatory peptides that maintain tissue homeostasis and can be used therapeutically to restore function in corresponding human organs (Khavinson, 2002).
The bone marrow is the primary site of hematopoiesis — the production of all blood cell lineages including erythrocytes, leukocytes, and platelets. Age-related decline in bone marrow function contributes to immunosenescence, anemia, and impaired response to infection. Bonomarlot is designed to deliver tissue-specific regulatory peptides that support bone marrow stem cell activity, promote normal hematopoietic differentiation, and help restore blood cell production compromised by aging or external stressors.
Mechanism of Action
Hematopoietic Stem Cell Support
The peptide fractions in Bonomarlot are proposed to interact with bone marrow stromal cells and hematopoietic stem cells, modulating the microenvironment that governs stem cell self-renewal and differentiation. Research on Khavinson bioregulators has demonstrated that short peptides can penetrate cell nuclei and interact directly with DNA at gene promoter regions, activating transcription of tissue-specific proteins (Khavinson et al., 2012). In bone marrow, this mechanism is proposed to upregulate genes involved in hematopoietic growth factors, cytokine signaling, and stem cell maintenance.
Immune Reconstitution
By stimulating the production of immune cell precursors in bone marrow, Bonomarlot may support downstream immune function. Bone marrow-derived progenitors give rise to B-lymphocytes, natural killer cells, monocytes, and dendritic cells. Age-related decline in these precursor populations contributes significantly to immunosenescence. The peptide bioregulators in Bonomarlot are proposed to counteract this decline by restoring proliferative capacity in aging bone marrow tissue.
Cytoprotection
Consistent with other Khavinson bioregulators, the peptide fractions in Bonomarlot may exert cytoprotective effects through modulation of apoptotic pathways and antioxidant gene expression. Research on related peptide preparations has shown reduction in oxidative stress markers and normalization of cell death rates in aging tissues (Khavinson & Malinin, 2005).
Reconstitution Calculator
Reconstitution Calculator
Calculate your peptide dosing
Set up a clean workspace with all supplies ready.
7x / week for weeks
Research
Myelosuppression Recovery
The primary research interest in bone marrow bioregulators centers on recovery from myelosuppression — the reduction of bone marrow activity that occurs following chemotherapy, radiation exposure, or as a consequence of aging. Khavinson's group has published extensively on the use of tissue-specific peptide preparations to restore organ function in aging and disease models. In the context of bone marrow, the goal is to accelerate the recovery of hematopoietic stem cell populations and normalize blood cell counts following suppressive insults.
Combination with Immune Bioregulators
Bonomarlot is often studied in combination with thymus-targeting bioregulators such as Vladonix and immune peptides like Vilon and Thymosin Alpha-1. The rationale is that bone marrow produces the precursor cells that subsequently mature in the thymus and peripheral lymphoid organs. Supporting both the production site (bone marrow) and the maturation site (thymus) may provide synergistic immune reconstitution benefits in aging individuals.
Age-Related Hematopoietic Decline
Aging is associated with a progressive reduction in hematopoietic stem cell function, shifting differentiation toward myeloid lineages at the expense of lymphoid output. This myeloid skewing contributes to reduced adaptive immunity and increased susceptibility to infection in elderly populations. Research on peptide bioregulators suggests that tissue-specific preparations can partially reverse age-related functional decline by reactivating gene expression programs that become silenced during senescence (Khavinson et al., 2021).
Safety Profile
Bonomarlot has been used in Russia as part of bioregulator protocols with no significant adverse effects reported in available literature. As a complex preparation of naturally occurring short peptides, it is expected to be rapidly metabolized with minimal accumulation. However, formal pharmacokinetic and toxicology studies in peer-reviewed Western literature are lacking. Individuals with hematological malignancies should exercise caution, as stimulation of bone marrow proliferation could theoretically affect disease progression. No drug interactions have been formally characterized.
Pharmacokinetic Profile
- Half-life
- Not established
Quick Start
- Route
- Oral (capsules)
Molecular Structure
- Formula
- Not applicable (multi-component preparation)
- CAS
- Not available
Research Protocols
oral
Administered via oral.
Interactions
Peptide Interactions
Bonomarlot is often studied in combination with thymus-targeting bioregulators such as Vladonix and immune peptides like Vilon and Thymosin Alpha-1. The rationale is that bone marrow produces the precursor cells that subsequently mature in the thymus and peripheral lymphoid organs. Supporting bot...
Bonomarlot is often studied in combination with thymus-targeting bioregulators such as Vladonix and immune peptides like Vilon and Thymosin Alpha-1.
Bonomarlot is often studied in combination with thymus-targeting bioregulators such as Vladonix and immune peptides like Vilon and Thymosin Alpha-1.
Bonomarlot is often studied in combination with thymus-targeting bioregulators such as Vladonix and immune peptides like Vilon and Thymosin Alpha-1.
Quality Indicators
What to look for
- Naturally occurring compound
Frequently Asked Questions
References (5)
- [2][Khavinson VK et al. (2012). Peptides tissue-specifically stimulate cell differentiation during their aging. Bull Exp Biol Med (2012)
- [1][Khavinson VK (2002). Peptides and Ageing. Neuro Endocrinol Lett (2002)
- [3][Khavinson VK & Malinin VV (2005). Gerontological aspects of genome peptide regulation. Karger (2005)
- [4][Khavinson VK et al. (2021). Peptide Regulation of Gene Expression: A Systematic Review. Molecules (2021)
- [5][Ashapkin V et al. (2020). Gene expression in human mesenchymal stem cell aging cultures: modulation by short peptides. Mol Biol Rep (2020)
Bombesin / Gastrin-Releasing Peptide (GRP)
Bombesin is a 14-amino acid peptide originally isolated from the skin of the European fire-bellied toad (Bombina bombina). Its mammalian homolog, gastrin-releasing peptide (GRP), signals through the GRP receptor (BB2/GRPR) which is overexpressed in prostate, breast, and lung cancers. Radiolabeled bombesin analogs such as 68Ga-RM2 are under investigation for PET imaging and receptor-targeted radiotherapy, while bombesin's roles in appetite regulation and GI motility continue to be explored.
Botulinum Toxin
Botulinum toxin is a potent neurotoxin produced by Clostridium botulinum that blocks acetylcholine release at neuromuscular junctions through SNARE protein cleavage. It is widely used therapeutically for dystonia, chronic migraine, hyperhidrosis, and cosmetically as Botox for dynamic wrinkle reduction.